Hyperlipidemia Drug Market Expanding through Bempedoic Acid and Oral Non-Statin Combinations
The growing focus on personalized cardiovascular care is expanding therapeutic choices for patients struggling with elevated cholesterol levels and statin intolerance. Detailed analysis within the Hyperlipidemia Drug Market report shows that oral non-statin lipid-lowering agents are securing a central role in modern lipid management algorithms. Bempedoic acid works upstream of the statin...
0 Комментарии 0 Поделились